On 2026-07-30, Contineum Therapeutics, Inc. (CTNM) announced earnings per share of $-0.40 for the fiscal quarter ending 2026-06-30, beating the average analyst estimate of $-0.46.
The next expected annoucement date for quarterly earnings is 2026-10-29, with an average estimated earnings per share of $-0.45 for the fiscal quarter ending 2026-09-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-07-30 | 2026-06-30 | $-0.46 | $-0.40 |
| 2026-05-05 | 2026-03-31 | $-0.55 | $-0.39 |
| 2026-03-05 | 2025-12-31 | $-0.50 | $-0.49 |
| 2025-10-30 | 2025-09-30 | $-0.58 | $-0.45 |
| 2025-08-05 | 2025-06-30 | $-0.56 | $-0.62 |
| 2025-05-14 | 2025-03-31 | $-0.56 | $-0.62 |
| 2025-03-06 | 2024-12-31 | $-0.44 | $-0.56 |
| 2024-11-06 | 2024-09-30 | $-0.41 | $-0.40 |
| 2024-08-13 | 2024-06-30 | $-0.37 | $-0.39 |
| 2024-05-16 | 2024-03-31 | $-0.53 | $-3.55 |